Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
New financings back 60 Degrees Pharma (NASDAQ: SXTP) infectious disease pipeline
60 Degrees Pharmaceuticals (NASDAQ: SXTP) has secured several multi-million-dollar equity financings from 2024 to 2026 to support its infectious disease pipeline. The company is actively developing tafenoquine for various new indications, including babesiosis and lung infections, while also marketing Arakoda for malaria prevention. These funding initiatives involve at-the-market offerings and registered direct offerings, enabling the expansion of clinical trials and commercialization efforts.